Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06899776 · ClinicalTrials.gov registry record
Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department
A clinical trial of ACS (Acute Coronary Syndrome), sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- 600
- Enrollment target
- 3
- Study locations
NCT06899776: Active study of ACS (Acute Coronary Syndrome), sponsored by Wake Forest University Health Sciences.
NCT06899776 is a study of ACS (Acute Coronary Syndrome) that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 600 participants. The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06899776, a study of ACS (Acute Coronary Syndrome), is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this proposal is to improve the quality and value of care for patients with acute chest pain by investigating the potential impact of point-of-care (POC) high sensitivity cardiac troponin (hs-cTn) testing in the Emergency Department (ED) and exploring how best to integrate POC hs-cTnl into ED risk stratification workflows. The study hypothesizes that the Abbott i-STAT POC hs-cTnI assay will decrease time-to-result (TTR) and ED length of stay (LOS), while increasing ED revenue for patients with acute chest pain compared to a strategy of central laboratory hs-cTnI testing.
Primary Outcome
Defined as the time from blood collection to result time of the hs-cTnI assay, as recorded by research staff for the Abbott i-STAT POC device and by the electronic health record for central lab Beckman Coulter Access 2 hs-cTnI measures. TTR will be collected for each troponin test ordered and collected in the Emergency Department (typically two tests per patient).
Conditions Studied
Interventions
- DEVICE Abbott i-STAT point of care (POC) device
Study Locations (3)
North Carolina
- Carolinas Medical Center - Charlotte
- High Point Medical Center - High Point
- Wake Forest School of Medicine - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-02-07 |
| Est. Completion | 2026-07 |
What the registry record for NCT06899776 still lists
NCT06899776 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with ACS (Acute Coronary Syndrome) appearing as the primary indexed condition, and to 1 intervention - of which Abbott i-STAT point of care (POC) device is the first listed.
NCT06899776 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06899776 about?
NCT06899776 is a clinical study titled "Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department". The goal of this proposal is to improve the quality and value of care for patients with acute chest pain by investigating the potential impact of point-of-care (POC) high sensitivity cardiac troponin (hs-cTn) testing in the Emergency Department (ED) and exploring how best to integrate POC hs-cTnl in...
What is the current status of trial NCT06899776?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2025-02-07. Estimated completion is 2026-07.
What conditions does trial NCT06899776 study?
This clinical trial studies the following conditions: ACS (Acute Coronary Syndrome).
What interventions are being tested in trial NCT06899776?
The interventions under investigation include: Abbott i-STAT point of care (POC) device (DEVICE).
Who is sponsoring clinical trial NCT06899776?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06899776 being conducted?
This trial has 3 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ACS (Acute Coronary Syndrome)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI